424 Early Outcomes of the Insides Chyme Reinfuser (ICR) in the Management of High-Output Stoma

Abstract Aim High-output stomas present a significant surgical, nursing, nutritional and patient challenge. Patients are at risk of complications ranging from disrupted GI renal physiology to severe vascular access. The ICR device allows chyme be reinfused may promising way establish early enteral feeding, shorten hospital stays, reduce such as losses prolonged parenteral feeding. We aimed investigate the outcome in our initial cohort patients. Method Prospective analysis all patients using 2020-2022. Outcomes included: primary pathology, stay, duration Parenteral nutrition, albumin level, commencement tolerance Chyme reinfusion, mortality. Results Eight used ICR. Five became independent device. Four were successfully reversed with one waiting reversal. In patients, reduction nutrition was noted five nutritionally autonomous whilst Although an imperfect marker, levels responded use (an average improvement 31g/L 38g/L). One died due pathology. Conclusions is safe effective. It can by nursing most Our data suggest possible TPN which will have financial clinical benefits. should considered selected There remains considerable mortality co-morbidity who left high-output stoma.